190 related articles for article (PubMed ID: 21489304)
1. Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.
Wang YS; Cao R; Jin H; Huang YP; Zhang XY; Cong Q; He YF; Xu CJ
J Hematol Oncol; 2011 Apr; 4():15. PubMed ID: 21489304
[TBL] [Abstract][Full Text] [Related]
2. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
3. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
Zhang AM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
[TBL] [Abstract][Full Text] [Related]
5. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
6. SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin.
Li C; Bai Y; Yan L; Zhang L; Zhang H; Li M; Zhao M; Gao Y; Zhao X
Gynecol Obstet Invest; 2016; 81(3):267-74. PubMed ID: 26334303
[TBL] [Abstract][Full Text] [Related]
7. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
Qian J; Weber D; Cochran R; Hossain D; Bostwick DG
Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199
[TBL] [Abstract][Full Text] [Related]
8. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
9. [Serum E2 and progesterone levels in patients with atypical hyperplasia and endometrial carcinoma].
Gorchev G; Maleeva A
Akush Ginekol (Sofiia); 1993; 32(2):23-4. PubMed ID: 8010393
[TBL] [Abstract][Full Text] [Related]
10. Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples.
Robbe EJ; van Kuijk SM; de Boed EM; Smits LJ; van der Wurff AA; Kruitwagen RF; Pijnenborg JM
Int J Gynecol Cancer; 2012 Sep; 22(7):1264-72. PubMed ID: 22872167
[TBL] [Abstract][Full Text] [Related]
11. The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions.
Yılmaz SA; Altınkaya SÖ; Kerimoglu ÖS; Tazegül Pekin A; Akyürek F; Ilhan TT; Benzer N; Unlu A; Yuksel H; Celik C
J Obstet Gynaecol; 2017 Jan; 37(1):58-63. PubMed ID: 28006994
[TBL] [Abstract][Full Text] [Related]
12. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
[TBL] [Abstract][Full Text] [Related]
13. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
14. Serum tumour necrosis factor alpha levels in benign and malignant lesions of the endometrium in postmenopausal women. A preliminary study.
Shaarawy M; Abdel-Aziz O
Acta Oncol; 1992; 31(4):417-20. PubMed ID: 1632976
[TBL] [Abstract][Full Text] [Related]
15. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
[TBL] [Abstract][Full Text] [Related]
16. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Allison KH; Upson K; Reed SD; Jordan CD; Newton KM; Doherty J; Swisher EM; Garcia RL
Int J Gynecol Pathol; 2012 Mar; 31(2):151-159. PubMed ID: 22317873
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
Li XC; Song WJ
Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry.
DeSouza LV; Grigull J; Ghanny S; Dubé V; Romaschin AD; Colgan TJ; Siu KW
Mol Cell Proteomics; 2007 Jul; 6(7):1170-82. PubMed ID: 17374602
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.
Ørbo A; Kaino T; Arnes M; Larsen K; Pettersen I; Moe B
Acta Obstet Gynecol Scand; 2009; 88(11):1234-42. PubMed ID: 19900140
[TBL] [Abstract][Full Text] [Related]
20. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
